These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 28342482)

  • 1. Treatment outcomes in veterans with HPV-positive head and neck cancer.
    Feinstein AJ; Shay SG; Chang E; Lewis MS; Wang MB
    Am J Otolaryngol; 2017; 38(2):188-192. PubMed ID: 28342482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of Human Papillomavirus-Associated Head and Neck Cancers in a Veteran Population.
    Shay SG; Chang E; Lewis MS; Wang MB
    JAMA Otolaryngol Head Neck Surg; 2015 Sep; 141(9):790-6. PubMed ID: 26270931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
    Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
    J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
    Linge A; Lohaus F; Löck S; Nowak A; Gudziol V; Valentini C; von Neubeck C; Jütz M; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Buchholz F; Aust DE; Baretton GB; Thames HD; Dubrovska A; Alsner J; Overgaard J; Krause M; Baumann M;
    Radiother Oncol; 2016 Dec; 121(3):364-373. PubMed ID: 27913065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
    Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment.
    Salazar CR; Smith RV; Garg MK; Haigentz M; Schiff BA; Kawachi N; Anayannis N; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
    Head Neck Pathol; 2014 Mar; 8(1):77-87. PubMed ID: 24002971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer.
    Yan F; Li H; Kaczmar JM; Sharma AK; Day TA; Neskey DM; Pipkorn P; Zenga J; Graboyes EM
    JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1109-1119. PubMed ID: 32790830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in head and neck cancer patients: impact of HPV and primary treatment modality.
    Maxwell JH; Mehta V; Wang H; Cunningham D; Duvvuri U; Kim S; Johnson JT; Ferris RL
    Laryngoscope; 2014 Jul; 124(7):1592-7. PubMed ID: 24353066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papilloma virus status evaluation and survival description in selected oropharyngeal and laryngeal squamous cell carcinoma patients from Hungary.
    Reka Fejer E; Abram Z; Zs Egyed J; Voidazan S; Toth E; Szentirmay Z; Kasler M
    J BUON; 2016; 21(1):168-74. PubMed ID: 27061545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staging and treatment of oropharyngeal cancer in the human papillomavirus era.
    Ward MJ; Mellows T; Harris S; Webb A; Patel NN; Cox HJ; Piper K; Ottensmeier CH; Thomas GJ; King EV
    Head Neck; 2015 Jul; 37(7):1002-13. PubMed ID: 24753272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma.
    Dixon PR; Au M; Hosni A; Perez-Ordonez B; Weinreb I; Xu W; Song Y; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    Head Neck; 2016 Sep; 38(9):1347-53. PubMed ID: 27002481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
    Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
    Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Human Papilloma Virus and Risk Factors among Patients with Head and Neck Squamous Cell Carcinoma Attending a Tertiary Referral Centre in South India.
    Bandhary SK; Shetty V; Saldanha M; Gatti P; Devegowda D; R PS; Shetty AK
    Asian Pac J Cancer Prev; 2018 May; 19(5):1325-1330. PubMed ID: 29802694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of human papillomavirus infection in oral squamous cell carcinoma: a cohort study of Japanese patients.
    Kouketsu A; Sato I; Abe S; Oikawa M; Shimizu Y; Takahashi T; Kumamoto H
    J Oral Pathol Med; 2016 Sep; 45(8):565-72. PubMed ID: 26711722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment response of HPV-positive and HPV-negative head and neck squamous cell carcinoma cell lines.
    Nagel R; Martens-de Kemp SR; Buijze M; Jacobs G; Braakhuis BJ; Brakenhoff RH
    Oral Oncol; 2013 Jun; 49(6):560-6. PubMed ID: 23578372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemoradiation therapy with high-dose versus weekly cisplatin for resected, locally-advanced HPV/p16-positive and negative head and neck squamous cell carcinoma.
    Geiger JL; Lazim AF; Walsh FJ; Foote RL; Moore EJ; Okuno SH; Olsen KD; Kasperbauer JL; Price DL; Garces YI; Ma DJ; Neben-Wittich MA; Molina JR; Garcia JJ; Price KA
    Oral Oncol; 2014 Apr; 50(4):311-8. PubMed ID: 24467937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research progress in pathogenesis, treatment and prognosis of HPV positive head and neck squamous cell carcinoma].
    Shui CY; Li C; Liu W; Cai YC; Jiang J; Sun RH; Zhou YQ; Qin G
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):392-396. PubMed ID: 29764025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.